Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients

BAKKALOĞLU EZGÜ, SEVCAN; KANDUR, YAŞAR; Serdaroglu, Erkin; Noyan, Aytul; KARABAY BAYAZIT, AYSUN; Tasdemir, Mehmet; Ozlu, Sare; Ozcelik, Gul; DURSUN, İSMAİL; Alparslan, Caner; Akcaboy, Meltem; Atikel, Yesim; Parmaksiz, Gonul; ATMIŞ, BAHRİYE; Sever, Lale

doi:10.1007/s00467-018-4013-4

Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients

Copy For Citation

BAKKALOĞLU EZGÜ S. A., KANDUR Y., Serdaroglu E., Noyan A., KARABAY BAYAZIT A., Tasdemir M., ...More

PEDIATRIC NEPHROLOGY, vol.33, no.11, pp.2143-2150, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 33 Issue: 11
Publication Date: 2018
Doi Number: 10.1007/s00467-018-4013-4
Journal Name: PEDIATRIC NEPHROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.2143-2150
Keywords: Dialysis, Hemoglobin cycling, Left ventricular hypertrophy, Pediatric patients, LEFT-VENTRICULAR HYPERTROPHY, CHRONIC KIDNEY-DISEASE, HEMODIALYSIS-PATIENTS, LEVEL VARIABILITY, BLOOD-PRESSURE, ANEMIA, ERYTHROPOIETIN, MORTALITY, ASSOCIATIONS, CHILDREN
Çukurova University Affiliated: Yes

Abstract

During erythropoietin-stimulating agent (ESA) treatment, hemoglobin (Hb) levels usually fluctuate; this phenomenon is known as "Hb cycling (HC)." In this study, we aimed to evaluate the predictors of HC and its impact on left ventricular hypertrophy (LVH) as a patient-important outcome parameter in pediatric dialysis patients.